Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v4-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-02-19 | 2025-02-19 |
| Drug Identification Number | 02462303 | 02462303 |
| Brand name | AMPICILLIN SODIUM FOR INJECTION BP | AMPICILLIN SODIUM FOR INJECTION BP |
| Common or Proper name | AMPICILLIN SODIUM FOR INJECTION BP | AMPICILLIN SODIUM FOR INJECTION BP |
| Company Name | AURO PHARMA INC | AURO PHARMA INC |
| Ingredients | AMPICILLIN | AMPICILLIN |
| Strength(s) | 250MG | 250MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 10ml x10 | 10ml x10 |
| ATC code | J01CA | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2024-08-12 | 2024-08-12 |
| Estimated end date | Unknown | Unknown |
| Actual end date | 2025-02-18 | 2025-02-18 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Please be informed that AMPICILLIN SODIUM FOR INJECTION BP will be transferred to the Eugia label, DIN:02530473 | Please be informed that AMPICILLIN SODIUM FOR INJECTION BP will be transferred to the Eugia label, DIN:02530473 |
| Health Canada comments |